The COPDA1 gene (Candidate Obesity Gene in Adipose Tissue 1) is a gene that has been studied for its roles in adipose tissue biology, metabolism, and potential associations with obesity and related disorders.

### Summary of COPDA1 Gene 

- **Gene Symbol**: COPDA1
- **Function**: Although specific details about the function of COPDA1 may be less well-characterized, it is implied to be related to processes involving obesity, potentially through interactions with adipose tissue.

### 1. Associated Genes
While specific associated genes may not be extensively documented, COPDA1 could have functional relationships or regulatory interactions with other genes involved in metabolic pathways, adipogenesis, and obesity. Potential associated genes may include:
- Leptin (LEP)
- Adiponectin (ADIPOQ)
- Fatty acid synthase (FASN)

It is advisable to refer to gene-protein interaction databases or networks for more specific associations.

### 2. Aging and Age-Related Diseases
COPDA1 has been implicated in obesity, which is a significant risk factor for various age-related diseases, including type 2 diabetes, cardiovascular diseases, and certain cancers. While the gene itself may not be directly linked to aging, its role in obesity and metabolic syndrome suggests a potential influence on aging-related health outcomes. Studies exploring the differential expression of COPDA1 in aged versus young tissues, as well as associations with inflammation and metabolic dysregulation often encountered in aging, could provide insights regarding its relevance in age-related conditions.

### 3. Drug Interactions
As of my last update in October 2023, specific drugs or drug classes that interact directly with COPDA1 may not be well-established. However, drugs targeting metabolic pathways, such as those affecting insulin sensitivity (e.g., metformin) or using lipid-altering substances (e.g., statins), may indirectly influence the pathways involving COPDA1. To identify specific drug interactions or candidates, databases that specialize in drug-gene interactions or databases like DrugBank may provide more targeted insights.

### 4. Pathways and Biological Processes
COPDA1 may be involved in several biological processes and pathways, relevant to metabolism and obesity. Potential areas might include:
- **Adipogenesis**: Involvement in the differentiation of pre-adipocytes into adipocytes.
- **Energy Metabolism**: Contributing to cellular metabolism pathways influenced by adipose tissue.
- **Inflammatory Response**: Potential roles in inflammatory pathways that are often implicated in obesity and metabolic disturbances.
- **Insulin Signaling**: Indirect roles in pathways related to insulin sensitivity and resistance mechanisms.

For precise and updated details regarding pathways, referencing pathway databases such as KEGG or Reactome could yield more insights into specific biological processes linked to COPDA1.

In conclusion, while COPDA1 is primarily explored within the context of metabolism and obesity, further research could unveil deeper insights into its associations with aging, related genes, potential drug interactions, and its involvement in key biological processes.